ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

ETX E-therapeutics Plc

9.45
-0.325 (-3.32%)
Last Updated: 13:12:37
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
E-therapeutics Plc LSE:ETX London Ordinary Share GB00B2823H99 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.325 -3.32% 9.45 9.25 9.50 9.45 9.45 9.45 445,192 13:12:37
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 475k -8.27M -0.0142 -6.88 57.04M
E-therapeutics Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker ETX. The last closing price for E-therapeutics was 9.78p. Over the last year, E-therapeutics shares have traded in a share price range of 8.00p to 24.00p.

E-therapeutics currently has 583,844,162 shares in issue. The market capitalisation of E-therapeutics is £57.04 million. E-therapeutics has a price to earnings ratio (PE ratio) of -6.88.

E-therapeutics Share Discussion Threads

Showing 276 to 298 of 2200 messages
Chat Pages: Latest  16  15  14  13  12  11  10  9  8  7  6  5  Older
DateSubjectAuthorDiscuss
26/6/2019
16:43
I took a few hundred K today. Volume most probably taken woof WOOF out for good.
altered carbon
26/6/2019
16:42
if hes foxtrot oscar'd for the time being might get a derisk bounce - lot of blue on the hourlies
luckymouse
26/6/2019
16:25
Haven’t been able to get a quote for the past 15 mins...
74tom
26/6/2019
16:14
Offered same price to buy and sell?
herb clark
26/6/2019
16:10
Being offered 1,75 for 200k shares
herb clark
26/6/2019
16:06
That could well be the case!
pre
26/6/2019
16:05
Pre make that 11% Looks like the mms may have started this rally to assist Woodfords last batch
woolybadger62
26/6/2019
15:59
Woodbadger62-exactly, rns confirming TR1 re:woodford holding is what i meant, not saying speeding ticket..not after such a dramatic fall.
pre
26/6/2019
15:55
Pre why would an Rns come out its only 26% up. May get another TR1 conforming Woodford reduction holding. But wnt get any speeding ticket for a small rise.
woolybadger62
26/6/2019
15:54
need a rns to see what's going on...
pre
26/6/2019
15:51
Not sure why RNS has not been released?
herb clark
26/6/2019
15:51
He has prob kept some, there was a 5m sale before suspect that was a sell. He may be done for now as he was reducing his holdings across his portfolio and not selling out completely, remember he bought as he saw value that fact hasn't changedThis was a high of 42pKeep that in mind. I've been watching this one until the buyers came back. Will be over 2p soon and will motor
woolybadger62
26/6/2019
15:51
RNS imminent. Then we’ll see these fly!
cudmore
26/6/2019
15:49
woodford held 37.9 million shares....how many does he still hold or has he stopped selling??
pre
26/6/2019
15:43
Woodford must be out now or has stopped
woolybadger62
26/6/2019
15:43
Plenty of upside here
woolybadger62
26/6/2019
15:42
Cash £5.9m - enough until 2021? Directors bought at 2.8p in April? Edison report values company at £69.4m or 24p/share - x14 to current price of 1.6p? Recent collaboration with Novo Nordisk focusing on type-2 diabetes? 'Potential M&A deals' & 'partner talks'
woolybadger62
26/6/2019
15:39
7p 1st stop
woolybadger62
26/6/2019
15:15
I am guessing Woody should be out soon
alexios1201
26/6/2019
15:06
Medical World


@MedicalWorld110
1h1 hour ago
More
Cancer Research, UK top funded charity, to fund only 2 cannabinoid clinical trials, 1 for synthetic cannabinoid Dexanabinol by e-Therapeutics & another Sativex, cannabis plant extract by GW Pharma.

h2owater
26/6/2019
15:04
Cancer Research, UK top funded charity, to fund only 2 cannabinoid clinical trials, 1 for synthetic cannabinoid Dexanabinol by e-Therapeutics & another Sativex, cannabis plant extract by GW Pharma.
soupdragon55
25/6/2019
20:46
Is this a good buy once Woodford has sold ?
bangbang1
25/6/2019
07:39
Many thanks
harvey26311
Chat Pages: Latest  16  15  14  13  12  11  10  9  8  7  6  5  Older

Your Recent History

Delayed Upgrade Clock